EdgarLookup

Translational Development Acquisition Corp. — Quarterly Financials

Quarterly figures from SEC EDGAR XBRL filings (10-Q)

These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Translational Development Acquisition Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.

Overview All Filings Annual Quarterly Insiders

Net Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 $1.66M Nov 14, 2025
Q3 2025 Jun 30, 2025 $1.62M Nov 14, 2025
Q2 2025 Jun 30, 2025 $1.62M Aug 14, 2025
Q3 2025 Mar 31, 2025 $1.48M Nov 14, 2025
Q1 2025 Mar 31, 2025 $1.48M May 15, 2025
Q2 2025 Mar 31, 2025 $1.48M Aug 14, 2025
Q3 2025 Sep 30, 2024 ($61.3K) Nov 14, 2025
Q3 2025 Jun 30, 2024 ($1.7K) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($1.7K) Aug 14, 2025
Q2 2025 Mar 31, 2024 $0 Aug 14, 2025
Q1 2025 Mar 31, 2024 $0 May 15, 2025
Q3 2025 Mar 31, 2024 $0 Nov 14, 2025

Operating Income — By Quarter

Quarter Fiscal Year Period End Value Filed
Q3 2025 Sep 30, 2025 ($213.7K) Nov 14, 2025
Q2 2025 Jun 30, 2025 ($221.1K) Aug 14, 2025
Q1 2025 Mar 31, 2025 ($347.4K) May 15, 2025
Q3 2025 Sep 30, 2024 ($61.3K) Nov 14, 2025
Q2 2025 Jun 30, 2024 ($1.7K) Aug 14, 2025
Q1 2025 Mar 31, 2024 $0 May 15, 2025